DIRS.INFO The most relevant business & tech news

☆ ATP roundup: Daniil Medvedev headlines day of sweeps at Vienna
▼ + stars: | 2023-10-26 | by ( ) www.reuters.com time to read: +2 min

Overall, Medvedev won 28 of 31 first-service points while collecting 16 winners against just three unforced errors. Sinner topped American Ben Shelton 7-6 (2), 7-5; Gojo ousted Russia's Aslan Karatsev 6-3, 6-3; and Monfils downed Daniel Altmaier of Germany 6-4, 6-4. In second-round action, fifth-seeded German Alexander Zverev downed Great Britain's Cameron Norrie 6-2, 6-4, while No. Swiss Indoors BaselArgentina's Tomas Martin Etcheverry rallied to beat Andy Murray of Great Britain 6-7 (5), 6-3, 6-2 in a second-round match at Basel, Switzerland. 4 seed Hurbert Hurkacz of Poland also won his second-round match, sweeping German Jan-Lennard Struff 6-1, 6-4.

Persons: Russia's Daniil Medvedev, Sebastian Korda, Aly, Daniil Medvedev, Frenchman Arthur Fils, Fils, Medvedev, Italy, Borna Gojo, Gael Monfils, Sinner, Ben Shelton, Gojo, Russia's Aslan Karatsev, Monfils, Daniel Altmaier, Alexander Zverev, Britain's Cameron Norrie, Karen Khachanov, Jiri Lehecka, Basel Argentina's Tomas Martin Etcheverry, Andy Murray of, Etcheverry, Murray, Lennard, Casper Ruud, Taylor Fritz, Felix Auger, France's Ugo Humbert Organizations: Shanghai, Sports City Arena, U.S, REUTERS, Erste Bank, Swiss, Basel Argentina's, Thomson Locations: Shanghai, China, Vienna, Croatian, Germany, Russia, Czech, Andy Murray of Great Britain, Basel, Switzerland, Poland

☆ Mark Rothko at Full Scale, and in Half Light
▼ + stars: | 2023-10-25 | by ( Jason Farago | More About Jason Farago | ) www.nytimes.com time to read: +1 min

Melt the world away, lose its details, dissolve its borders; it doesn’t sound like such an unwelcome prospect right now. The most substantial Mark Rothko retrospective in a generation has opened at the Fondation Louis Vuitton, and it is a show of monumental dispersion: a pull-out-all-the-stops blockbuster where life passes into vapor. From 1949, when his early figurative pictures finally liquefied into stains of translucent color, Rothko painted with no allusions, no particulars. A lot of people find his large paintings consoling, or seek the Romantic sublime in the depths of his reds and violets. “Behind the color lies the cataclysm,” he said in 1959 — a citation that rarely makes the auction preview catalogs.

Persons: Rothko, Fondation Louis Vuitton, ”, it’s, Frank Gehry Organizations: Fondation, Art Basel, National Gallery of Art, Whitney, Fondation Vuitton, Boulogne Locations: Paris, Washington, New York, Bois

☆ ATP roundup: Top seed Holger Rune rallies in Basel
▼ + stars: | 2023-10-25 | by ( ) www.reuters.com time to read: +2 min

1 seed Holger Rune of Denmark bounced back from a rough first set to beat Serbia's Miomir Kecmanovic 1-6, 7-5, 6-3 in first-round action at the Swiss Indoors Basel on Tuesday. Rune overcame four double faults and 15 unforced errors by winning 30 of his 43 first-service points (69.8 percent). 4 seed Hubert Hurkacz of Poland beat Serbia's Dusan Lajovic 7-6 (2), 6-3, while fifth seed Alex de Minaur of Australia beat Diego Schwartzman of Argentina 6-4, 6-4. 4 seed Stefanos Tsitsipas of Greece beat home-country favorite Dominic Thiem 7-6 (5), 6-4 in the first round in Vienna, Austria. 3 seed Andrey Rublev of Russia defeated Australia's Alexei Popyrin 7-6 (5), 6-4, and American sixth seed Tommy Paul took care of Frenchman Alexandre Muller 6-3, 6-1.

Persons: Holger Rune, Brandon Nakashima, Aly, Denmark, Serbia's, Rune, Hubert Hurkacz, Serbia's Dusan Lajovic, Alex de Minaur, Diego Schwartzman, Nicolas Jarry of, Frenchman Adrian Mannarino, Tallon Griekspoor, Russian Alexander Shevchenko, Dominic Stricker, Dominic Thiem, Tsitsipas, Andrey Rublev, Australia's Alexei Popyrin, Tommy Paul, Frenchman Alexandre Muller, Frances Tiafoe, Daniel Evans of Great, Grigor Dimitrov of, Tomas Machac, Lorenzo Sonego Organizations: Shanghai, Sports City Arena, U.S, REUTERS, Swiss, Basel, Australia, Erste Bank, Russia, Thomson Locations: Shanghai, China, Poland, Argentina, Nicolas Jarry of Chile, Netherlands, Russian, Swiss, Greece, Vienna, Austria, American, U.S, Daniel Evans of Great Britain, Grigor Dimitrov of Bulgaria, Czech

☆ ATP roundup: Sebastian Korda sent packing early in Basel
▼ + stars: | 2023-10-23 | by ( ) www.reuters.com time to read: +1 min

Korda fired eight aces to Etcheverry's two and won 33 of 39 first-serve points (84.6 percent), but Etcheverry moved on after saving four of six break points and breaking Korda twice in three opportunities. Dutch qualifier Botic van de Zandschulp beat Spaniard Roberto Bautista Agut 7-5, 6-7 (3), 6-2 in three hours, three minutes. 5 seed Alexander Zverev of Germany made quick work of Austrian wild card Sebastian Ofner, winning 6-4, 6-1 in the first round in Vienna. 8 seed Karen Khachanov defeated Roman Safiullin 6-4, 6-4 in a match between Russians. Cameron Norrie of Great Britain, Matteo Arnaldi of Italy and Jiri Lehecka of the Czech Republic also advanced.

Persons: Sebastian Korda, Argentina's Francisco Cerundolo, Aly, Tomas Martin Etcheverry, Korda, Etcheverry, Botic van, Zandschulp, Roberto Bautista Agut, Andy Murray of Great, Germany's Yannick Hanfmann, Argentina's Sebastian Baez, Germany's Jan, Lennard Struff, Alexander Zverev, Sebastian Ofner, Ofner, Zverev, Karen Khachanov, Roman Safiullin, Cameron Norrie, Matteo Arnaldi, Jiri Lehecka Organizations: Shanghai, Sports City Arena, Swiss, Basel, Erste Bank, Austrian, Thomson Locations: Shanghai, China, Argentina, Germany, Vienna, Great Britain, Italy, Czech Republic

New Roche CEO Thomas Schinecker is keen to restore Roche's battered drug development record after major late-stage trial setbacks in the areas of Alzheimer's and cancer immunotherapy last year. The acquired drug, against inflammatory bowel disease such as ulcerative colitis and Crohn's disease, belongs to a class of new treatments known as anti-TL1A antibodies which has attracted major deal activity in the pharma industry. Merck & Co (MRK.N) in April agreed to buy anti-TL1A antibody developer Prometheus Biosciences for $10.8 billion. Inflammatory bowel disease is a group of chronic gastrointestinal disorders with almost 8 million people diagnosed worldwide and 80% of all individuals not experiencing lasting remission, Roche said. "We strongly believe this novel TL1A directed antibody has the transformational potential to make a significant difference for patients living with inflammatory bowel disease and potentially other diseases," said Roche CEO Schinecker.

Persons: drugmaker Roche, Arnd, New Roche, Thomas Schinecker, Schinecker, Roche, John Revill, Ludwig Burger, Friederike Heine, Jason Neely Organizations: REUTERS, Roivant Holdings, Pfizer Inc, pharma, Sanofi, Merck & Co, Prometheus Biosciences, Thomson Locations: Basel, Switzerland, ZURICH, FRANKFURT, Swiss, U.S, Japan, Zurich, Frankfurt

Four thousand U.S. dollars are counted out by a banker counting currency at a bank in Westminster, Colorado November 3, 2009. REUTERS/Rick Wilking/File Photo Acquire Licensing RightsWASHINGTON, Oct 20 (Reuters) - A trio of U.S. banking regulators announced on Friday they were giving the public extra time to digest and provide feedback on a broad proposal to raise bank capital requirements that is already facing fierce industry pushback. The regulators are similarly extending the window for a separate proposal that would raise a capital surcharge for the largest global banks. Firms have warned the proposal if finalized could force them to curtail lending, curb product offerings, and lead to economic harm. The "Basel Endgame" proposal implements international capital standards agreed by the Basel Committee on Banking Supervision in the aftermath of the 2007-2009 financial crisis.

Persons: Rick Wilking, Banks, Pete Schroeder, Andrea Ricci Organizations: REUTERS, Rights, Federal Reserve, Federal Deposit Insurance Corporation, Currency, Regulators, Banking, Fed, Thomson Locations: Westminster , Colorado

☆ Royalty Pharma to pay $1 bln for Roche's SMA drug royalties
▼ + stars: | 2023-10-19 | by ( ) www.reuters.com time to read: +1 min

The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland February 1, 2018. REUTERS/Arnd Wiegmann/File Photo Acquire Licensing RightsOct 19 (Reuters) - Royalty Pharma (RPRX.O) said on Thursday it has purchased additional royalties on Roche (ROG.S) and PTC Therapeutics' (PTCT.O) oral spinal muscular atrophy (SMA) drug for an upfront payment of $1 billion. Spinal muscular atrophy, a leading genetic cause of infant deaths, prevents the body from producing a protein necessary for neuromuscular development. The deal also includes options for PTC to sell up to all of its retained royalties on Evrysdi for up to $500 million at a later date, Royalty Pharma said. Royalty Pharma expects to fund the transaction with a combination of existing cash and about $350 million from its revolving credit facility.

Persons: drugmaker Roche, Arnd, Roche, Mariam Sunny, Shilpi Majumdar Organizations: REUTERS, Royalty Pharma, PTC Therapeutics, U.S . Food, Drug Administration, PTC, Thomson Locations: Basel, Switzerland, Bengaluru

☆ Exclusive: Lilly hires CordenPharma to make diabetes drug Mounjaro's active ingredient -source
▼ + stars: | 2023-10-19 | by ( Maggie Fick | ) www.reuters.com time to read: +3 min

An Eli Lilly and Company pharmaceutical manufacturing plant is pictured at 50 ImClone Drive in Branchburg, New Jersey, March 5, 2021. REUTERS/Mike Segar/File Photo Acquire Licensing RightsLONDON, Oct 19 (Reuters) - Eli Lilly (LLY.N) has hired Switzerland-based contract drugmaker CordenPharma to produce the active ingredient in its diabetes drug Mounjaro, a source familiar with the matter told Reuters on Thursday. Lilly has said it expects U.S. approval for Mounjaro for weight loss by the end of the year. The source told Reuters that CordenPharma's factory in Colorado is under contract to make tirzepatide, the active ingredient in the weekly injection. Analysts estimate the obesity market could be worth as much as $100 billion in the next decade.

Persons: Eli Lilly, Mike Segar, drugmaker, CordenPharma, Lilly, Corden, Maggie Fick, Josephine Mason, Bill Berkrot Organizations: Company, REUTERS, Reuters, CordenPharma, Novo Nordisk, Mounjaro, Thomson Locations: Branchburg , New Jersey, Switzerland, United States, Colorado, Basel, Europe, Boulder , Colorado, Boulder

☆ Roche's Q3 sales down 3% on currency headwinds, drop in COVID sales
▼ + stars: | 2023-10-19 | by ( Ludwig Burger | ) www.reuters.com time to read: +2 min

Quarterly sales came in at 14.3 billion Swiss francs ($15.9 billion), the Swiss drugs and diagnostics maker said in a statement, broadly in line with analyst estimates. A high-dose version of Eylea for less frequent injections won U.S. approval in August, creating doubt among analysts that a string of forecast-beating Vabysmo sales can continue. CEO Thomas Schinecker - who is keen to restore Roche's drug development record - said he was looking to acquire drug assets in all stages of development but that there was no rush. He pointed to 10% sales growth during the quarter, excluding currency headwinds and the slump in COVID sales. However, it predicted a less pronounced decline in sales of COVID-19 products of about 4.5 billion Swiss francs, from a previous estimate of a drop of 5 billion francs.

Persons: drugmaker Roche, Arnd, Roche, Regeneron, Thomas Schinecker, Schinecker, Ludwig Burger, Friederike Heine, Elaine Hardcastle Organizations: REUTERS, Bayer, Thomson Locations: Basel, Switzerland, COVID, Swiss

☆ Basel proposes crypto disclosures by banks from January 2025
▼ + stars: | 2023-10-17 | by ( ) www.reuters.com time to read: +1 min

The Basel Committee of banking regulators from the world's main financial centres agreed new rules last December on how much capital banks should hold to cover different types of cryptoassets. On Tuesday, they set out for public consultation how the holdings should be disclosed to investors. "Under the proposals, banks would be required to disclose qualitative information on their activities related to cryptoassets and quantitative information on exposures to cryptoassets and the related capital and liquidity requirements," the Basel Committee said in a statement. Banks would also be required to provide details of the accounting classifications of their exposures to cryptoassets and crypto liabilities, it said. Reporting by Huw Jones; Editing by Kirsten Donovan and Emelia Sithole-MatariseOur Standards: The Thomson Reuters Trust Principles.

Persons: Dado Ruvic, Banks, Jan, Huw Jones, Kirsten Donovan, Emelia Organizations: REUTERS, Global, Committee, Thomson Locations: cryptoassets

☆ David Solomon’s Goldman remix is audibly off-key
▼ + stars: | 2023-10-17 | by ( John Foley | ) www.reuters.com time to read: +4 min

NEW YORK, Oct 17 (Reuters Breakingviews) - Having given up a side-gig in DJ-ing, Goldman Sachs (GS.N) boss David Solomon has one less distraction. Goldman reported a one-third year-on-year drop in earnings on Tuesday, in a quarter riddled with one-off charges. Those included a hit related to buy-now-pay-later lender GreenSky, which Goldman bought only two years ago, and is selling. Absent all that, Goldman would have made a return on equity of just over 10%. Goldman made a 7.1% return on equity in the quarter, on an annualized basis, which would have been 10.2% without one-off charges.

Persons: Goldman Sachs, David Solomon, Goldman, GreenSky, Morgan Stanley, Solomon, Marc Nachmann, Nachmann, Jonathan Guilford, Sharon Lam Organizations: Reuters, JPMorgan, Thomson Locations: tomorrow’s, Basel, GreenSky

A Citi sign is seen at the Citigroup stall on the floor of the New York Stock Exchange, October 16, 2012. REUTERS/Brendan McDermid/File Photo Acquire Licensing RightsWASHINGTON, Oct 13 (Reuters) - Big bank executives warned a number of products and services could become uneconomical if new proposed bank capital hikes are adopted as written, but said they were hopeful they could win some changes. Citi Chief Financial Officer Mark Mason said the proposal would lead to a 16% to 20% increase in the bank's capital. The bank is reviewing products and operations, he said, highlighting equity investments, which will also be deemed much riskier under the rules. Citi is also reviewing credit products and where they may need to reprice those, and whether they need to restructure any of their markets positions.

Persons: Brendan McDermid, Jeremy Barnum, Barnum, Michael Barr, Banks, Mark Mason, Mason, Wells, Michael Santomassimo, Santomassimo, Tatiana Bautzer Organizations: Citi, Citigroup, New York Stock Exchange, REUTERS, Rights, Big, JPMorgan, . Federal, Basel III, Thomson Locations: Wells Fargo, Basel

☆ Jamie Dimon makes anxiety a feature not a bug
▼ + stars: | 2023-10-13 | by ( John Foley | ) www.reuters.com time to read: +4 min

The mega-bank Jamie Dimon runs is performing strongly, and yet he openly frets and rants about what’s coming: higher interest rates, smothering regulation, recession, war. Lest nerves be soothed by those trends, Dimon lays on caveats with a trowel. Dimon can afford to dwell on the negative because JPMorgan is strong and liquid. If calamity strikes, JPMorgan’s high returns, high capital levels and sheer size make it akin to a safe haven. It also slightly reduced its forecast of expenses and credit-card write-offs from numbers given with second-quarter earnings.

Persons: Jamie Dimon, Marco Bello, delinquencies, Wells, Dimon, Peers, Jane Fraser, hasn’t, Jeffrey Goldfarb, Sharon Lam, Aditya Sriwatsav Organizations: JPMorgan Chase &, Chase, Business The, Miami, REUTERS, Reuters, JPMorgan, Citigroup, Basel, Citi, Reuters Graphics, Thomson Locations: East, Ukraine

☆ Wells Fargo remains a stock to own, as the bank reports stellar quarterly results
▼ + stars: | 2023-10-13 | by ( Zev Fima | ) www.cnbc.com time to read: +9 min

Bottom line Wells Fargo's quarterly revenue outpaced expectations on the back of better-than-expected results for both net interest income (NII) and non-interest income. Middle-market banking revenue increased 23% year-over-year, as higher interest rates and loan balances were only partially offset by lower deposits. Asset-based lending and leasing revenue was up 3% annually, a result of loan growth and increased revenue from renewable energy investments. Total banking revenues increased 20% year-over-year, a result of higher rates and lending revenues, along with "higher investment banking revenue on increased activity across all products." Commercial real estate revenue increased 14% year-over-year, due to higher rates and revenue growth in the firm's low-income housing business.

Persons: Wells, Wells Fargo, we've, Charlie Scharf, Wall, Scharf, NII, Jim Cramer's, Jim Cramer, Jim, Justin Sullivan Organizations: Wells, Basel III, Management, Consumer, Auto, CNBC, Wells Fargo Bank Locations: Wells Fargo, Basel, U.S, San Bruno , California

[1/2] A 0.25 mg injection pen of Novo Nordisk's weight-loss drug Wegovy is shown in this photo illustration in Oslo, Norway, September 1, 2023. REUTERS/Victoria Klesty/Illustration/File Photo Acquire Licensing RightsOct 12 (Reuters) - Novo Nordisk (NOVOb.CO) warned on Thursday of a surge in counterfeit versions of its weight-loss drug Wegovy and diabetes drug Ozempic offered online, as German authorities gave more details of complex European trades in a fake drug case. "Novo Nordisk has seen a significant increase in illegal online sales," the company said in a statement, referring to products that contain the active ingredient semaglutide. The warning came after Germany's federal drug regulator on Wednesday urged pharmacies and drug distributors to be vigilant following the discovery of wholesale batches of fake Ozempic. The FDA has warned patients to refrain from using a compounded drug if an approved drug is available.

Persons: Victoria Klesty, Ozempic, Novo, Danish drugmaker, Eli Lilly, Lilly, Maggie Fick, Ludwig Burger, Jan Harvey, Susan Fenton Organizations: REUTERS, Novo Nordisk, Nordisk, Prosecutors, U.S . Food, Drug Administration, U.S, FDA, Thomson Locations: Oslo, Norway, Victoria, Loerrach, Swiss, Basel, British, Austria, Germany, Europe, Danish, U.S, United States, Britain

☆ Here are 3 stocks in our portfolio that Goldman Sachs think will rally on earnings
▼ + stars: | 2023-10-12 | by ( Zev Fima | ) www.cnbc.com time to read: +5 min

It's encouraging to see three Club stocks on the bullish side of Goldman Sachs' new list of 25 tactical trades for earnings season. The Goldman research analysts think Wells Fargo's management has "adequately de-risked its NIM [net interest margin] guidance to incorporate potentially higher-for-longer policy rates." HUM YTD mountain Humana YTD Humana (HUM) — which trades at 15.8 times forward earnings estimates — was highlighted by Goldman analysts who are "positive on the company's 2024 outlook." Nvidia — the Club's only other "own it, don't trade it" stock besides Apple (AAPL) — trades at 31.1 times forward earnings estimates. The Goldman Sachs logo is seen on at the New York Stock Exchange on September 13, 2022 in New York City.

Persons: Goldman Sachs, Goldman, Wells, YTD Goldman Sachs, It's, Jim Cramer's, Jim Cramer, Jim, Michael M Organizations: Humana, Nvidia, WFC, Apple, CNBC, New York Stock Exchange, Santiago, Getty Locations: Wells, Wells Fargo, New York City

REUTERS/Kevin Lamarque/ Acquire Licensing RightsWASHINGTON, Oct 9 (Reuters) - The U.S. Federal Reserve's top regulatory official defended a sweeping proposal to overhaul bank capital rules before the country's largest bank lobby on Monday, arguing the benefits of a bigger cushion outweigh any additional costs banks might face. The proposal implements international capital standards agreed by the Basel Committee on Banking Supervision in the aftermath of the 2007-2009 financial crisis. Barr's Monday speech, which is his first on bank regulation since the proposal came out, served as a broad-based defense of the effort. "The private costs of capital must be weighed against the social benefits of higher capital in creating a healthier, more resilient financial system," he said, according to prepared remarks. Barr also pushed back against the industry's refrain that higher capital costs for banks will mean curtailed lending and potential economic harm.

Persons: Michael Barr, Kevin Lamarque, Michael Barr's, Barr, Jerome Powell, Powell, Isaac Boltansky, Pete Schroeder, Michelle Price, Josie Kao, Andrea Ricci Organizations: Financial, Valley Bank, Signature Bank, Capitol, REUTERS, Rights, U.S, Federal, Banking, Silicon Valley Bank, Thomson Locations: Washington , U.S, Silicon

Failure to secure the cash they need at rates they can afford, could lead to insolvencies and layoffs. "I think we're now starting to finally see the fall of some of the zombies," she added. This can include restructuring loan repayments, offering reduced rates or other more relaxed terms and can help banks avoid loan write-offs. "Banks and private equity shops have waited to see if the tide turned but higher rates don't allow hiding anymore." Any large corporate failures are likely to have a "contamination effect", said Tim Metzgen, an A&M managing director.

Persons: Dado Ruvic, Alvarez, Julie Palmer, Begbies Traynor, we're, Begbies, Nicola Marinelli, Banks, Paul Kirkbright, Kirkbright, Eva Shang, Katie Murray, Naresh Aggarwal, Ravi Anand, Anand, Tim Metzgen, Jane Merriman Organizations: REUTERS, Reuters, Britain's, National Statistics, Casino, Regent's University, of England, Bank of, Finance, M's, NatWest Group, Association of Corporate, Companies, Thomson Locations: Europe, Middle East, Africa, England, Wales, U.S, Basel III

☆ Metro Bank: Shares in UK bank just plunged over 30%
▼ + stars: | 2023-10-05 | by ( Anna Cooban | ) edition.cnn.com time to read: +4 min

London CNN —Shares in UK lender Metro Bank sank as much as 31% Thursday following a report that it was urgently seeking to raise funds to shore up its finances. Metro Bank opened in 2010 as the first challenger to Britain’s major main street banks — including Lloyds (LYG), Barclays (BCS) and HSBC (HSBC) — in more than 100 years. Metro Bank’s assurances did little to support its share price, which pared some of its earlier losses but was down by 31% again by late afternoon in London. The bank’s shares are down almost 66% since mid-September when UK regulators refused its request to change the way it calculates capital requirements on its residential mortgages book. A Metro Bank branch in the UK city of Sheffield, seen in April Mike Egerton/APThe ratings agency noted that Metro Bank had to refinance a £350 million ($425 million) bond by October 2024.

Persons: “, Fitch, ” Fitch, Mike Egerton, Chris Beauchamp, isn’t, ”, — Hanna Ziady Organizations: London CNN —, Metro Bank, Financial Times, Lloyds, Barclays, BCS, HSBC, —, Metro, Bank, UK Financial, Prudential Regulation Authority, Bank of England, IG, CNN, Financial, Metro Bank . CNN, Prudential, Banking Supervision, Valley Bank, Signature Bank, First Republic Bank, Credit Suisse — Locations: ”, London, Sheffield, United States, United Kingdom, Basel

☆ Banks in EU largely comply with 'Basel Endgame', says watchdog
▼ + stars: | 2023-09-26 | by ( Huw Jones | ) www.reuters.com time to read: +3 min

The global Basel Committee agreed additional capital rules in 2017 that require banks to hold bigger reserves to shield them from potential shocks. The EU, along with Britain and the United States, is now putting the final Basel requirements into its rule books. Basel has a 2028 deadline for implementing its remaining rules, which are set to be rolled out in the EU from January 2025. The BoE is due to set out its final Basel Endgame rules sometime in 2024. The aggregate shortfalls globally and in the EU represent a fraction of banks' total capital buffers and earnings.

Persons: Arnd, BoE, Huw Jones, Jacqueline Wong, Jane Merriman Organizations: Bank for International Settlements, REUTERS, Union, Basel, European Banking Authority, Basel III, United, Bank of England, EU, Committee, Thomson Locations: Basel, Switzerland, EU, Britain, United States, Banks

☆ Pakistan probes distributors of Roche cancer drug after patients go blind
▼ + stars: | 2023-09-25 | by ( Mubasher Bukhari | ) www.reuters.com time to read: +3 min

REUTERS/Arnd Wiegmann/File Photo Acquire Licensing RightsLAHORE, Pakistan, Sept 25 (Reuters) - Pakistan said on Monday it was investigating two local distributors of Swiss pharmaceutical company Roche's (ROG.S) Avastin cancer drug after 12 diabetic patients injected with the drug went blind. The Drug Regulatory Authority of Pakistan (DRAP) said the health authorities in Punjab, the most populous province, had launched the investigation into local use of the drug Avastin, which is licensed for use in Pakistan. On its website, Roche said Avastin was approved in more than 130 countries, including the United States, to treat several types of cancer. Cancer drug Avastin, when used at much lower doses, is similar to eye drug Lucentis and is used in many countries as a low-cost option to treat certain blindness-causing conditions. In its statement, Roche said: "Avastin is not approved for any use in the eye.

Persons: drugmaker Roche, Arnd, Javed Akram, Akram, Roche, Avastin, Alam, Mubasher Bukhari, Ariba Shahid, Ludwig Burger, Miral Fahmy, Alex Richardson Organizations: REUTERS, Rights, Drug Regulatory Authority of Pakistan, Reuters, U.S ., Thomson Locations: Basel, Switzerland, Rights LAHORE, Pakistan, Swiss, Punjab, United States, counterfeits, Avastin, Lahore, Karachi, Frankfurt

☆ I made $124,000 last year answering people's questions about their antiques. Here's how I turned my passion into a remote job that gave me financial freedom.
▼ + stars: | 2023-09-22 | by ( Ella Hopkins | ) www.businessinsider.com time to read: +6 min

I moved to New York, where I landed a job with a fine-art gallery and auction house. I left the art scene in New York and worried how I'd be able to make a living from art and antiques there. For a while, I sold antiques I'd bought on eBay and Etsy and did freelance work for clients in New York. I wanted to work in antiques remotelyI wanted to be able to work from home helping people around the world identify the value of art, antiques, and collectibles. This job gave me financial freedom, and I was able to buy a houseI was especially busy during the COVID-19 pandemic.

Persons: Nora Curl, Rookwood, Nelson Shanks, Ronald Reagan, Bill Clinton, I'd, — there's, I'm, There's, I've, Samuel Clemens, Samual Clemens, Mark Twain Organizations: Art, Art Basel, eBay, Mayflower Locations: Pennsylvania, Los Angeles, New York, London, Miami, Christie's, England, JustAnswer

☆ Why so many buildings in Singapore are covered in plants
▼ + stars: | 2023-09-19 | by ( Eliza Relman | ) www.businessinsider.com time to read: +4 min

Singapore is trying to fight rising temperatures partly by making its buildings greener, literally. One central strategy is to literally make the city greener by covering rooftops and the facades of buildings with plants. Under its Skyrise Greenery Incentive Scheme, Singapore pays property owners up to 50% of the cost of installing green rooftops and facades. And the green buildings can attract tourists looking to patronize eco-friendly businesses. Toronto passed a law in 2009 requiring that buildings of a certain size have green roofs.

Organizations: Service, Nanyang Technological University Locations: Singapore, Sands, Basel, Switzerland, Toronto

The logo of Swiss contract drug maker Lonza is seen at its headquarters in Basel, Switzerland October 1, 2020. Shares in Lonza, which makes drug ingredients for healthcare and biotech companies, dropped 5.3% shortly after the 0700 GMT market open, trading near an eight-month low. A former Roche executive who joined Lonza in 2020, Ruffieux oversaw the company's role in producing COVID-19 vaccines for Moderna (MRNA.O) during the pandemic. "Today’s announcement increases our conviction that the new mid-term targets will not include an acceleration in growth," they said. Lonza did not provide a reason for Ruffieux's departure.

Persons: Arnd, Pierre, Alain Ruffieux, Lonza, Albert Baehny, Ruffieux, Morgan, Spokespeople, Merck KGaA, Noele, Ludwig Burger, Rachel More, David Goodman, Emelia Organizations: REUTERS, Monday, Ruffieux, Roche, Lonza, Moderna, Merck, Noele Illien, Thomson Locations: Basel, Switzerland, Swiss, Lonza, Zurich, Frankfurt

☆ SocGen's new boss Krupa pledges to cut costs to boost profits by 2026
▼ + stars: | 2023-09-18 | by ( ) www.cnbc.com time to read: +2 min

Societe Generale's new CEO Slawomir Krupa pledged on Monday to cut costs to boost profits by 2026 amid stagnating sales, in his first strategic plan for France's third-biggest listed bank. SocGen said it would target a 9 to 10% return on tangible equity ratio (ROTE) in 2026, up from a reported 5.6% ROTE at the end of June. The bank also said that it would reduce its exposure to upstream oil and gas businesses by 80% by 2030 when compared to 2019. SocGen said its new targets were based on annual revenue growth expectations between 0 and 2% by 2026. SocGen is also open to a sale of its equipment finance unit, sources have told Reuters.

Persons: Slawomir Krupa, Krupa, ambitioned, SocGen Organizations: Generale's, Basel Committee, Reuters, Finance, BNP Locations: Basel, Russia, Ukraine

Search resuls for: "BASEL"

25 mentions found